Results 91 to 100 of about 43,988 (208)
Overproduction and Characterization of Recombinant Soluble Trypanosoma brucei Phospholipase A2
Engineering in Life SciencesTrypanosoma brucei phospholipase A2 (TbPLA2) is a validated drug target but the difficulty in expressing its soluble recombinant protein has limited its exploitation for drug and vaccine development for African and American trypanosomiases.
Oluwafemi Abiodun Adepoju +9 more
doaj +1 more source
MoleculesFolk medicine is widely used in Angola, even for human African trypanosomiasis (sleeping sickness) in spite of the fact that the reference treatment is available for free.
Nina Vahekeni +13 more
doaj +1 more source
PharmaceuticsBackground: Neglected tropical diseases (NTDs), including leishmaniasis, trypanosomiasis, and schistosomiasis, impose a significant public health burden, especially in developing countries.
Jacqueline Soto-Sánchez +1 more
doaj +1 more source
Tropical Medicine and Infectious DiseaseChagas disease, caused by Trypanosoma cruzi, remains a neglected tropical disease with limited and often suboptimal chemotherapeutic treatment options.
Ana Lia Mazzeti +4 more
doaj +1 more source
Benefit-Cost Analysis and Socio-Economic Considerations of Trypanosomiasis Control and Treatment in Northern Ghana [PDF]
The paper estimates the cost of tsetse control and treatment of trypanosomiasis and the benefits involved, using benefit-cost analysis. It also estimates the extent to which socio-economic characteristics of farmers affect the use of tsetse control ...
Asuming-Brempong, Samuel, Wahab, S.
core +1 more source
Cerebral trypanosomiasis and AIDS
Arquivos de Neuro-Psiquiatria, 2002 A 36 year-old black female, complaining of headache of one month's duration presented with nausea, vomiting, somnolence, short memory problems, loss of weight, and no fever history. Smoker, intravenous drugs abuser, promiscuous lifestyle.
Antunes Apio Claudio Martins +6 more
doaj